The global Famciclovir API market was valued at US$ 13 million in 2022 and is projected to reach US$ 16 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Famciclovir API market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Famciclovir API market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Famciclovir API market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
This report aims to provide a comprehensive presentation of the global market for Famciclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir API. This report contains market size and forecasts of Famciclovir API in global, including the following market information:
- Global Famciclovir API Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Famciclovir API Market Sales, 2018-2023, 2024-2030, (MT)
- Global top five Famciclovir API companies in 2022 (%)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
We surveyed the Famciclovir API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Famciclovir API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Famciclovir API Market Segment Percentages, by Type, 2022 (%)
- Purity, 99%
- Purity, 98%
- Others
Global Famciclovir API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Famciclovir API Market Segment Percentages, by Application, 2022 (%)
- Tablet Product
- Capsule Product
- Others
Global Famciclovir API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Famciclovir API Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Famciclovir API revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Famciclovir API revenues share in global market, 2022 (%)
- Key companies Famciclovir API sales in global market, 2018-2023 (Estimated), (MT)
- Key companies Famciclovir API sales share in global market, 2022 (%)
key players include:
- Haihang Industry
- Manus Aktteva Biopharma
- Changzhou Kony Pharma Co
- Teva Pharmaceutical Industries
- Chongqing Shenghuaxi Pharma
- Aurobindo Pharma Limited
- Cipla
- Hanways Chempharm Co
Outline of Major Chapters:
Chapter 1: Introduces the definition of Famciclovir API, market overview.
Chapter 2: Global Famciclovir API market size in revenue and volume.
Chapter 3: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Famciclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Famciclovir API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
